Want to join the conversation?
$PRGO's Rx Pharmaceuticals segment posted 34% net sales growth due to increase in existing product sales & strong new product launches. Adjusted margins were unchanged due to continued investments in R&D and in its specialty pharma sales force. Specialty Sciences net sales were $85MM in 3Q15 and were essentially flat on a constant currency basis.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!